All Stories

  1. Rapid production of a chimeric antibody-antigen fusion protein based on 2A-peptide cleavage and green fluorescent protein expression in CHO cells
  2. Duality of β-glucan microparticles: antigen carrier and immunostimulants
  3. Cell type-specific differences in β-glucan recognition and signalling in porcine innate immune cells
  4. Interferon-gamma expression and infectivity of Toxoplasma infected tissues in experimentally infected sheep in comparison with pigs
  5. Clearance of Escherichia coli O157:H7 Infection in Calves by Rectal Administration of Bovine Lactoferrin
  6. Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF6
  7. Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF9
  8. Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF7
  9. Nanobody Mediated Inhibition of Attachment of F18 Fimbriae Expressing Escherichia coli
  10. Evaluation of the presence and zoonotic transmission of Chlamydia suis in a pig slaughterhouse
  11. Variation in 12 porcine genes involved in the carbohydrate moiety assembly of glycosphingolipids does not account for differential binding of F4 Escherichia coliand their fimbriae
  12. The immune response against Chlamydia suis genital tract infection partially protects against re-infection
  13. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization
  14. Development and Validation of a Real-Time PCR for Chlamydia suis Diagnosis in Swine and Humans
  15. Development of a method for isolating bovine colostrum mononuclear leukocytes for phenotyping and functional studies
  16. The immune response against Chlamydia suis genital tract infection partially protects against re-infection
  17. Isolation and genotyping of viable Toxoplasma gondii from sheep and goats in Ethiopia destined for human consumption
  18. Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenicEscherichia coliinfection
  19. Use of Antibody Responses against Locus of Enterocyte Effacement (LEE)-Encoded Antigens To Monitor Enterohemorrhagic Escherichia coli Infections on Cattle Farms
  20. The effect of enterotoxigenic Escherichia coli F4ab,ac on early-weaned piglets: A gene expression study
  21. Editorial
  22. ETEC vaccination in pigs
  23. Optimization of a small intestinal segment perfusion model for heat-stable enterotoxin A induced secretion in pigs
  24. Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants
  25. Emerging Chlamydia psittaci infections in the chicken industry and pathology of Chlamydia psittaci genotype B and D strains in specific pathogen free chickens
  26. Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB
  27. The Fcγ receptor expression profile on porcine dendritic cells depends on the nature of the stimulus
  28. Maltose-binding protein is a potential carrier for oral immunizations
  29. Seroepidemiological study of caprine toxoplasmosis in East and West Shewa Zones, Oromia Regional State, Central Ethiopia
  30. Seroepidemiological study of ovine toxoplasmosis in East and West Shewa Zones of Oromia Regional State, Central Ethiopia
  31. WITHDRAWN: Maltose-binding protein is a potential carrier for oral immunizations
  32. Structural insight in histo-blood group binding by the F18 fimbrial adhesin FedF
  33. Several enteropathogens are circulating in suckling and newly weaned piglets suffering from diarrhea in the province of Villa Clara, Cuba
  34. Role of Heat-Stable Enterotoxins in the Induction of Early Immune Responses in Piglets after Infection with Enterotoxigenic Escherichia coli
  35. Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response
  36. Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
  37. Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization
  38. Erratum to: “Adjuvant effect of Gantrez® AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli”
  39. Characterization and clonal grouping of pathogenic Escherichia coli isolated from intestinal contents of diarrheic piglets in Villa Clara province, Cuba, according to their antibiotic resistance and ERIC-PCR profiles
  40. Erratum to “Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli” [Vet. Immunol. Immunopathol. 139 (2011) 148–155]
  41. Erythrocyte and Porcine Intestinal Glycosphingolipids Recognized by F4 Fimbriae of Enterotoxigenic Escherichia coli
  42. Varying Effects of Different β-Glucans on the Maturation of Porcine Monocyte-Derived Dendritic Cells
  43. Reduction of Escherichia coli O157:H7 excretion in sheep by oral lactoferrin administration
  44. Sera from dams of calves with bovine neonatal pancytopenia contain alloimmune antibodies directed against calf leukocytes
  45. IFN-γ expression and infectivity of Toxoplasma infected tissues are associated with an antibody response against GRA7 in experimentally infected pigs
  46. Oral infection with a Shiga toxin-negative Escherichia coli O157:H7 strain elicits humoral and cellular responses but does not protect sheep from colonisation with the homologous strain
  47. Immunization of sheep with a combination of intiminγ, EspA and EspB decreases Escherichia coli O157:H7 shedding
  48. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa
  49. Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli
  50. High prevalence of F4+ and F18+ Escherichia coli in Cuban piggeries as determined by serological survey
  51. Vaccination against EHEC: insights from model in sheep
  52. Rectal inoculation of sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response
  53. Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells
  54. Clathrin-mediated endocytosis and transcytosis of enterotoxigenic Escherichia coli F4 fimbriae in porcine intestinal epithelial cells
  55. Oral administration of beta-1,3/1,6-glucan Macrogard® fails to enhance the mucosal immune response following oral F4 fimbrial immunisation in gnotobiotic pigs
  56. Validation of the Chlamydia trachomatis genital challenge pig model for testing recombinant protein vaccines
  57. Targeting of Escherichia coli F4 fimbriae to Fcγ receptors enhances the maturation of porcine dendritic cells
  58. The effect of β-glucans on porcine leukocytes
  59. Oral Administration of β-1,3/1,6-Glucan to Dogs Temporally Changes Total and Antigen-Specific IgA and IgM
  60. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus
  61. Identification of the Porcine C-type lectin dectin-1
  62. The food contaminant fumonisin B1reduces the maturation of porcine CD11R1+intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infection
  63. Effect of β-glucans on an ETEC infection in piglets
  64. The mucosal immunogenicity in pigs of F4(K88) fimbriae is decreased by reducing its polymeric stability
  65. Recognition of Blood Group ABH Type 1 Determinants by the FedF Adhesin of F18-fimbriated Escherichia coli
  66. Evaluation of the prophylactic use of ovotransferrin against chlamydiosis in SPF turkeys
  67. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization
  68. Effect of plasmid DNA encoding the porcine granulocyte–macrophage colony-stimulating factor on antigen-presenting cells in pigs
  69. Transcytosis of F4 fimbriae by villous and dome epithelia in F4-receptor positive pigs supports importance of receptor-dependent endocytosis in oral immunization strategies
  70. The excretion of F18+E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate
  71. The possibility of positive selection for both F18+ Escherichia coli and stress resistant pigs opens new perspectives for pig breeding
  72. Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection
  73. Production of penicillin-specific polyclonal antibodies for a group-specific screening ELISA
  74. Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection
  75. The age-dependent expression of the F18+ E. coli receptor on porcine gut epithelial cells is positively correlated with the presence of histo-blood group antigens
  76. Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine
  77. Vitamin E deficiency and decreased serum immunoglobulin concentrations in a population of donkeys
  78. Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA
  79. Optimized FaeG Expression and a Thermolabile Enterotoxin DNA Adjuvant Enhance Priming of an Intestinal Immune Response by an FaeG DNA Vaccine in Pigs
  80. Plasmid-encoded GM-CSF induces priming of the F4(K88)-specific serum IgA response by FaeG DNA vaccination in pigs
  81. The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae
  82. Effect of porcine respiratory coronavirus infection on lipopolysaccharide recognition proteins and haptoglobin levels in the lungs
  83. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
  84. F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets
  85. Immunocompetence in organically fed finishing pigs: Effect of corn cob mix
  86. Specific-Pathogen-Free Pigs as an Animal Model for Studying Chlamydia trachomatis Genital Infection
  87. The F18 fimbrial adhesin FedF is highly conserved among F18 isolates
  88. Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1α,25-dihydroxyvitamin D3
  89. The role of enterocytes in the intestinal barrier function and antigen uptake
  90. Penicillin-specific antibodies: Monoclonals versus polyclonals in ELISA and in an optical biosensor
  91. Fimbriae of enterotoxigenic Escherichia coli function as a mucosal carrier for a coupled heterologous antigen
  92. Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes
  93. Immunocompetence of fattening pigs fed organic versus conventional diets in organic versus conventional housing
  94. Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic infections
  95. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?
  96. Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG
  97. Binding of a monoclonal antibody positively correlates with bioactivity of the F4 fimbrial adhesin FaeG associated with post-weaning diarrhoea in piglets
  98. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response
  99. Conserved regions in the sequence of the F4 (K88) fimbrial adhesin FaeG suggest a donor strand mechanism in F4 assembly
  100. The interaction of F4 fimbriae with porcine enterocytes as analysed by surface plasmon resonance
  101. Inhibition of adhesion of F18+ Escherichia coli to piglet intestinal villous enterocytes by monoclonal antibody against blood group H-2 antigen
  102. Fimbrial Subunit Protein FaeG Expressed in Transgenic Tobacco Inhibits the Binding of F4ac Enterotoxigenic Escherichia coli to Porcine Enterocytes
  103. Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA
  104. Immunoblotting, ELISA and culture evidence for Chlamydiaceae in sows on 258 Belgian farms
  105. 1alpha ,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization
  106. B and T cell suppression in an Arabian horse with Rhodococcus equi infection
  107. F4 Fimbriae Expressed by Porcine Enterotoxigenic Escherichia coli, an Example of an Eccentric Fimbrial System?
  108. Influence of porcine intestinal pH and gastric digestion on antigenicity of F4 fimbriae for oral immunisation
  109. Gastrointestinal transit time of nondisintegrating radio-opaque pellets in suckling and recently weaned piglets
  110. Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections
  111. Generation of Group-Specific Antibodies against Sulfonamides
  112. Open status of pig-breeding farms is associated with slightly higher seroprevalence of F18+ Escherichia coli in northern Belgium
  113. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
  114. Reduced faecal excretion of F4+-E. coli by the intramuscular immunisation of suckling piglets by the addition of 1α,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides
  115. Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms
  116. Antigen dose modulates the immunoglobulin isotype responses of pigs against intramuscularly administered F4-fimbriae
  117. Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain
  118. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations
  119. F4 receptor-independent priming of the systemic immune system of pigs by low oral doses of F4 fimbriae
  120. Generation of Class-Selective Monoclonal Antibodies Against the Penicillin Group
  121. Induction of cross-protection in mice against dolphin Erysipelothrix rhusiopathiae isolates with a swine commercial vaccine
  122. Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization
  123. Enhanced induction of the IgA response in pigs by calcitriol after intramuscular immunization
  124. Enhanced specific antibody response to bovine serum albumin in pigeons due to L-carnitine supplementation
  125. The F4 fimbrial antigen of Escherichia coli and its receptors
  126. Identification of Ostertagia ostertagi specific cells in bovine abomasal lymph nodes
  127. A BIOSENSOR TO DETECT PENICILLIN RESIDUES IN FOOD
  128. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein
  129. Seroprevalence of F4+ enterotoxigenic Escherichia coli in regions with different pig farm densities
  130. Receptor-specific binding of purified F4 to isolated villi
  131. Antigenicity of cortical bone allografts in dogs and effect of ethylene oxide-sterilization
  132. Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations
  133. Expression of β2 integrins on blood leukocytes of cows with or without bovine leukocyte adhesion deficiency
  134. Induction and suppression of lymphocyte proliferation by antigen extracts of Ostertagia ostertagi
  135. Ostertagia ostertagi adult and fourth stage larvae antigen extract induce apoptosis of bovine abomasal lymph node lymphocytes in vitro
  136. Stimulation of the mucosal immune system in pigs after immunization with F4 fimbriae
  137. TGEV-specific IgA at different mucosae following infection of pigs with transmissible gastroenteritis virus or the antigenically related porcine respiratory coronavirus
  138. Modulation of the IgA antibody response in pigs following peripheral immunization
  139. No. III
  140. Inulin incorporation in the weaned pig diet: intestinal coliform interaction and effect on specific systemic immunity.